Will Revlimid be covered by health insurance?

Published: 2012-08-20 06:57:00

Updated: 2012-08-20 06:57:00

Will myeloma patients be able to get cheaper and better drugs this year? Now all eyes are on the Health Insurance Review and Assessment Service (HIRA) committee's decision on the reimbursement of Revlimid, a new drug for the disease, at the end of this month.

So far, the HIRA has barred reimbu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK